BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,549,000 | +14.0% | 756,358 | -1.2% | 0.00% | – |
| Q4 2018 | $2,235,000 | -69.4% | 765,358 | -35.6% | 0.00% | -100.0% |
| Q3 2018 | $7,315,000 | -46.5% | 1,187,578 | -35.9% | 0.00% | -50.0% |
| Q2 2018 | $13,664,000 | +4.4% | 1,851,555 | -7.2% | 0.00% | 0.0% |
| Q1 2018 | $13,085,000 | -40.8% | 1,994,672 | -24.1% | 0.00% | -33.3% |
| Q4 2017 | $22,114,000 | -29.9% | 2,629,542 | -3.7% | 0.00% | -25.0% |
| Q3 2017 | $31,547,000 | -3.2% | 2,731,342 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $32,589,000 | -7.6% | 2,790,142 | -2.4% | 0.00% | 0.0% |
| Q1 2017 | $35,276,000 | -24.6% | 2,858,677 | -16.8% | 0.00% | -33.3% |
| Q4 2016 | $46,784,000 | -31.8% | 3,434,964 | -0.3% | 0.01% | -33.3% |
| Q3 2016 | $68,548,000 | +121.0% | 3,444,606 | +43.9% | 0.01% | +125.0% |
| Q2 2016 | $31,020,000 | +168.6% | 2,393,544 | +93.8% | 0.00% | +100.0% |
| Q1 2016 | $11,547,000 | -70.0% | 1,235,000 | -34.9% | 0.00% | -60.0% |
| Q4 2015 | $38,441,000 | +164.6% | 1,896,454 | +89.6% | 0.01% | +150.0% |
| Q3 2015 | $14,530,000 | -31.7% | 1,000,000 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $21,270,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 22,374 | $105,000 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |